Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for DiaCarta Multiplex Coronavirus Test

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for DiaCarta's QuantiVirus SARS-CoV-2 Multiplex Test Kit.

The test is designed to detect the SARS-CoV-2 Orf1ab gene in upper respiratory specimens and sputum, according to Richmond, California-based DiaCarta. Nucleic acid purification is performed using either MGI Tech's MGIEasy Magnetic Beads Virus DBA/RNA Extraction Kit or Thermo Fisher Scientific's PureLink Viral RNA/DNA Mini Kit, and the test runs on Thermo Fisher's Applied Biosystems QuantStudio 5 RT-PCR instrument or Bio-Rad's CXF384 RT-PCR system.

The test may be used by any lab CLIA-certified to perform high-complexity tests.

In April, DiaCarta said it received EUA for its QuantiVirus SARS-CoV-2 Test Kit, which detects the virus' Orf1ab, N, and E genes.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.